Skip to main content

Retail Clinics

  • Study: CLIA waivers can empower pharmacists to fill PCP care gap

    FAIRFAX, Va. - Pharmacists and lab technicians are capable of absorbing the additional health management responsiblities currently being created by the reduction in primary care physicians, according to a new study published by the Mercatus Center at George Mason University. According to the Department of Health and Human Services, the physician shortage could reach as high as a shortage of 20,000 primary care physicians by 2020.

  • Fred’s offering flu vaccines as season kicks off

    MEMPHIS, Tenn. — Highlighting the more than 200,000 people hospitalized as a result of complications from the flu, Fred’s pharmacy announced Tuesday that it will be offering flu vaccines to help patients proactively protect against the flu. 
     
    Fred’s said that its pharmacists would work with patients to figure out which version of the flu vaccine is best for them. The company also noted that flu vaccines are free with most insurance plans, though copays may apply. 
     

  • Teva, IBM expand Watson Health Cloud collaboration

    LAS VEGAS — In a move aimed at addressing the two challenges of discovering new options for treatment and improving chronic disease management, Teva and IBM on Wednesday announced an expansion of their e-health alliance, with both projects running on the IBM Watson Health Cloud. 
     

  • ADA now recommends diabetics perform light activity every 30 minutes

    ALEXANDRIA, Va. - The American Diabetes Association on Tuesday released updated, comprehensive guidelines for regular, structured physical exercise for everyone with diabetes and recommends less overall sedentary time every day.

  • Dr. Reddy’s inks strategic deal for 8 injectables with Gland Pharma

    HYDERABAD, INDIA and PRINCETON, N.J. — Dr. Reddy’s Laboratories and Gland Pharma have announced a strategic collaboration to market and distribute eight injectable generics. 
     
    The portfolio includes hospital- and clinic-administered products for which abbreviated new drug applications (ANDAs) have been filed, and some whose ANDAs will be filed imminently, the companies said. The combined U.S. sales of the drugs for 12 months ending August 2016 were about $1 billion, according to IMS Health moving annual total data. 

  • Kaléo’s Auvi-Q auto-injector to return to U.S. in 2017

    RICHMOND, Va.  — Kaléo announced Wednesday that it will be reintroducing its Auvi-Q (epinephrine injection) auto-injector in the United States during the first half of 2017. This would bring another option to the epinephrine auto-injector space at a time when access and affordability in the space have seen focus from patients and legislators. 
     

  • CDC makes available $70 million in supplemental Zika virus funding

    ATLANTA - The Centers for Disease Control and Prevention on Friday announced the availability of about $70 million in supplemental funding to states, cities and territories to support continued efforts to protect Americans from Zika virus.

  • Hisamitsu launches Salonpas gel patch

    FLORHAM PARK, N.J. — Hisamitsu America has launched the new Salonpas Lidocaine 4% Pain Relieving Gel-Patch, the company announced Monday. The patch includes the maximum strength lidocaine available without a prescription and uses a proprietary hydro-gel technology to soothe aggravated nerves, the company said.
     
X
This ad will auto-close in 10 seconds